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Abstract: The aim of this study was the partial characterization of the an-
timicrobial peptide bacteriocin G2 produced by probiotic bacteria Lactobacillus 
plantarum G2, which was isolated from a clinical sample of a healthy person. 
Antimicrobial substance was secreted in the supernatant of an L. plantarum G2 
culture, and showed a diverse spectrum of antimicrobial activity of all the 
tested strains of the genera Lactobacillus and the pathogenic bacteria Staphylo-
coccus aureus and Salmonella аbony. Isoelectric focusing revealed that bac-
teriocin G2 is a cationic peptide (pI about 10) with a molecular mass of 2.2 kDa 
according to tricine–sodium dodecyl sulphate–polyacrylamide gel electropho-
resis, SDS-PAGE. The antimicrobial activity of bacteriocin G2 was diminished 
by the proteolytic action of trypsin and proteinase K. Bacteriocin G2 preserved 
its biological activity in the temperature range 40–60 °C (15 min), which was 
lost at 80 °C. Bacteriocin G2 was stable in the pH range 2–9, while treatment 
with 1 % Tween 80 and 1 % urea resulted in increased antimicrobial activity. 
The probiotic strain L. plantarum G2 produces the antimicrobial substance 
proteinaceous in nature with bacteriocin characteristics. Bacteriocin production 
is one of the key properties of probiotic bacteria with clinical potential as anti-
infective agents, which will increase the likelihood of its in vivo efficacy. 
Keywords: Lactobacillus plantarum; probiotic; bacteriocin. 
INTRODUCTION 
Bacteria employed in probiotic applications help to maintain or restore the 
natural microbial flora of a host. The ability of probiotic bacteria to successfully 
outcompete undesired species is often due to, or enhanced by, the production of 
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potent antimicrobial toxins.1 Some antimicrobial substances are non-specific, 
such as short-chain fatty acids or hydrogen peroxide, while others are specific 
with a very narrow killing range, such as bacteriocins, bacteriocin-like inhibitory 
substances (BLIS), and bacteriophages.2–4 Bacteriocins have been designated as 
bacterial substances with the capacity to inhibit, even in low concentrations, the 
multiplication of other taxonomically similar bacteria.5 They comprise a large 
and functionally diverse family of toxins found in all major lineages of Bacteria 
and Archaea, but there are certain features that unite them as a family; they are 
all ribosomally synthesized proteinaceous compounds and are active against bac-
teria closely related to the producing bacteria.6 In an attempt to organise this di-
verse family, bacteriocins are roughly classified into two main groups, the toxins 
produced by Gram-negative bacteria and those produced by Gram-positive bac-
teria.7 
Bacteriocins from Gram-positive bacteria are generally cationic, amphiphi-
lic, membrane-permeabilizing peptides, approximately 2–6 kDa in size.8 They 
are particularly attractive when the goal of probiotic application is to supplement, 
rather than dramatically alter, the natural bacterial flora of a host.1 Bacteriocin 
nisin was found to be safe for human consumption by the Food and Drug Ad-
ministration and has thus gained popularity in probiotic research.1 
Numerous strains of bacteriocin producing Lactobacillus plantarum have 
been isolated in the last two decades. Several of these plantaricins were charac-
terized and their amino acid sequence determined.9 
The aim of this work was to test bacteria with probiotic characteristics, L. 
plantarum G2, for antimicrobial peptide production. The antimicrobial spectrum 
and some properties of the bacteriocin G2 are described herein for the first time. 
EXPERIMENTAL 
Bacterial strains and growth media 
The bacteriocin G2 producing strain used in this study was isolated from a clinical 
sample of a healthy person, and according to its phenotypic and genotypic characteristics, it 
was classified as L. plantarum G2. The strain was stored at –20 °C in MRS (de Man, Rogosa 
and Sharpe, Merck) medium containing 15 % glycerol. MRS broth (Merck) was used for cell 
propagation. 
Indicator bacteria strains 
The bacteria used as indicator strains were: L. acidophilus ATCC 314, L. rhamnosus 
ATCC 7469, L. leishmany ATCC 7830, L. plantarum G1, L. casei G3, Enterococcus faecalis 
ATCC 29219, Staphylococcus aureus ATCC 6538–P, Pseudomonas aeruginosa ATCC 9027, 
Escherichia coli ATCC 8739, Klebsiella sp. ATCC 10031, Bacillus subtilis ATCC 6633, B. 
cereus ATCC 11178, Micrococcus luteus ATCC 93419, Salmonella abony ATCC 6017. 
L. leishmany ATCC 7830 was used as the indicator bacterium for the estimation of 
antimicrobial activity. 
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Production of bacteriocin G2 
For bacteriocin production, L. plantarum G2 cells were grown anaerobically (in 1000 ml 
Erlenmeyer flasks) in MRS broth (pH 6.4), at 37 °C and 58 rpm for 24 h, in rotary shaker 
incubator (Adolf Kühner, Switzerland). The culture was centrifuged at 4000 × g, for 20 min 
at 4 °C. The pH of the supernatant was adjusted to 6.5–7.0 with 1.0 M NaOH, to exclude the 
antimicrobial effect of organic acids, followed by filtration of the supernatant through a 0.2 
μm pore-size cellulose acetate filter (Sigma–Aldrich). The supernatant S was used for screen-
ing the antimicrobial activity. 
Detection of antimicrobial activity 
The antimicrobial activity of the bacteriocin produced by L. plantarum G2 was screened 
using the agar well diffusion (AWD) assay.10 Pre-poured MRS agar plates were overlain with 
0.1 mL suspension of the indicator strain (containing 106 CFU mL-1). Wells of 6 mm in 
diameter were cut into the agar plate using a cork borer and 100 μL of the supernatant S was 
placed into each well. After 18 h of incubation at 37 °C, the zone of inhibition (diameter) was 
measured. 
Bacteriocin assay  
The critical dilution assay described by Mayer-Hartings et al.11 was used to quantify the 
inhibitory activity of the bacteriocin against the respective sensitive indicator strain L. leish-
many. A serial two-fold dilution of the supernatant was made in 0.1 M Tris-HCl buffer, pH 7. 
The activity of each dilution was determined by the AWD assay. The antimicrobial activity is 
expressed in arbitrary units (AU mL-1). One AU is defined as the reciprocal of the highest 
dilution showing a clear zone of growth inhibition.  
Sensitivity to enzyme activity of bacteriocin G2 
To investigate the sensitivity of the bacteriocin to different enzymes (all obtained from 
Sigma), neutralized supernatant S samples of the tested strain were mixed with enzyme so-
lutions of catalase, pronase E, proteinase K, trypsin, chymotrypsin, lipase, lysozyme and α- 
-amylase (final enzyme concentration was 1 mg mL-1), incubated for 1 h at the optimum 
temperature for each of the enzymes and the residual activities were measured using the AWD 
assay. Two controls, one with sterile MRS and the respective enzyme (1 mg mL-1), and the 
other one with untreated bacteriocin were included. 
Heat resistance and pH stability of bacteriocin G2 
To determine the heat stability of bacteriocin G2, aliquots of the neutralized cell-free 
supernatant of tested strain were heated at 40, 60 and 80 °C for 15, 30, 60 and 90 min, and 
immediately cooled in an ice water bath. The heat resistance was also checked after auto-
claving the bacteriocin at 121 °C for 15 min. The residual bacteriocin activity was determined 
by the AWD assay.  
To test the stability at different pH, aliquots of neutralized supernatant were adjusted to 
pH values from 2–12 using 4 M HCl and 4 M NaOH, respectively and subsequently incubated 
for 1 h at 37 °C. The residual activities were measured after neutralizing the aliquots to pH 7.  
Sensitivity of bacteriocin G2 to surfactants 
To examine sensitivity of bacteriocin G2 to surfactants, SDS, Tween 80, Triton X-100 
and urea were used. Neutralized cell-free supernatant samples of tested strain were mixed with 
surfactants at a final concentration of 1 % (w/v) and incubated for 2 h at 37 °C. Residual 
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bacteriocin activities were measured using the AWD assay. The surfactants at a concentration 
of 1 % in neutralized MRS broth were used as controls. 
Preparation of crude supernatant  
Crude supernatant was prepared from 500 mL of an L. plantarum G2 culture. The cells 
were grown to the stationary phase in MRS broth at 37 °C. The cell-free supernatant of the 
culture was collected by centrifugation at 4000 × g for 20 min at 4 °C. To concentrate the 
produced bacteriocin G2 10-fold, the supernatant was filter sterilized (0.22 μm), and ultra-
filtrated on 5 kDa cut-off membrane (Millipore). The obtained solution, designated crude 
supernatant fluid, was used for bacteriocin characterization by electrophoretic methods, i.e., 
sodium dodecyl sulphate–polyacrylamide gel electrophoresis, SDS-PAGE, and isoelectric 
focusing. 
Reducing and non-reducing tricine SDS PAGE 
The molecular mass of bacteriocin G2 was estimated in a tricine–SDS-PAGE, as des-
cribed by Schagger and Von Jagow.12 To test for the presence of interchain disulphide bonds 
between the bacteriocin subunits or intrachain disulphide bonds essential for its activity, 
reducing and non-reducing sample buffers for the tricine–SDS-PAGE were used. 
Electrophoresis was performed in vertical gels (16.5 % acrylamide) at 30 V for 1 h, and 
90 V for 5 h. To determine the apparent molecular mass of the bacteriocin after tricine–SDS- 
-PAGE, the gel was cut into two slices. One half was fixed and stained with Coomassie Bril-
liant Blue. The other slice was assayed for antimicrobial activity according to Bhunia et al. 
(1987), with a slight modification.13 The gel prepared for growth inhibition was fixed in 20 % 
2-propanol and 10 % acetic acid for 5 min and washed in deionised water for 24 h. After-
wards, the gel was placed on a MRS prepared agar plate and overlaid with 20 mL of soft MRS 
agar seeded with L. leishmany (106 CFU mL-1). After incubation of the plate for 24 h at 37 °C, 
the location of the zone of growth inhibition was identified and photographed. For molecular 
mass determination, Amersham Low-Range Rainbow Molecular Weight Markers (3500– 
–40000 Da) were used. The protein standards molecular masses (Da) and colours were as 
follows: 38000, blue; 31000, orange; 24000, green; 17000, blue; 12000, red; 8500, yellow and 
3500, blue. 
Isoelectric focusing 
Isoelectric focusing, IEF, was performed at 10 °C in a Multiphor II electrophoresis unit 
according to the manufacturer’s instructions (Pharmacia). The isoelectric point was deter-
mined by using a broad pI calibration kit (pI 3.5–10, Pharmacia). After IEF, the gel was 
washed with distilled water for 30 s and cut into two slices. One slice was fixed and stained 
with Coomassie Brilliant Blue and the other one was assayed for antimicrobial activity by the 
agar overlay method described above. 
RESULTS AND DISCUSSION 
Spectrum of antimicrobial activity of bacteriocin G2 
To examine the effect of the bacteriocin from L. plantarum G2 on other mic-
roorganisms, neutralized cell-free supernatant was tested for antimicrobial acti-
vity against Gram-positive and Gram-negative bacteria by the well diffusion agar 
test. As shown in Table I, the bacteriocin was active against all the tested strains 
of the genera Lactobacillus: L. acidophilus, L. rhamnosus, L. leishmany, L. plan-
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tarum G1 and L. casei G3. The bacteriocin G2 also inhibited the growth of the 
pathogenic bacteria S. aureus and S. abony. Bacteriocin G2 displayed a relatively 
broad spectrum of antimicrobial activity as it inhibited 7 of the 14 indicator 
strains. 
TABLE I. Inhibitory activity of neutralized cell-free supernatant of L. plantarum G2 against 
various indicator strains, which is expressed as the diameter of the zone of inhibition 
Indicator organism Antimicrobial activity of bacteriocin G2a 
L. acidophilus ATCC 314 + 
L. rhamnosus ATCC 7469 + 
L. leishmany ATCC 7830 ++ 
L. plantarum G1 + 
L. casei G3 + 
E. faecalis ATCC 29219 – 
S. aureus ATCC 6538–P + 
P. aeruginosa ATCC 9027 – 
E. coli ATCC 8739 – 
Klebsiella sp. ATCC 10031 – 
B. subtilis ATCC 6633 – 
B. cereus ATCC 11178 – 
M. luteus ATCC 93419 – 
S. abony ATCC 6017 + 
a–: No inhibition zone; +: 5 mm < zone < 10 mm; ++: 10 mm < zone < 15 mm 
The inhibitory spectrum of bacteriocins produced by different species of 
lactobacilli varies greatly.14 Most bacteriocins inhibit only lactobacilli or closely 
related Gram-positive bacteria, whereas others are active against a broad spec-
trum of Gram-positive and Gram-negative bacteria.15–19 
Effect of enzymes, heat and pH on the antimicrobial activity of bacteriocin G2 
Bacteriocin G2 was tested for its sensitivity to various enzymes. The antibac-
terial activity was retained after catalase treatment, indicating that antibacterial 
activity was not due to H2O2. As shown in Table II, trypsin and proteinase K 
were the only proteases that partially or completely inhibited the antimicrobial 
activity. The fact that the bacteriocin was inactivated by trypsin and proteinase K 
indicates its proteinaceous nature, however, despite this, the substance was rather 
persistent to proteolytic cleavage of pronase E and chymotrypsin. Most bacterio-
cins are resistant to all proteolytic enzymes, but a few of them, including nisin, 
plantaricin C, plantaricin D, are sensitive to the actions of some proteases.20–24 
The antimicrobial activity of bacteriocin G2 was not affected by lipase, lysozyme 
or α-amylase, suggesting that its biological activity was not dependent on the 
presence of a lipid or sugar moiety. 
Incubation of the neutralized supernatant containing bacteriocin G2 at diffe-
rent temperatures for 15, 30 and 90 min showed that it was completely stable up 
____________________________________________________________________________________________________________________________
2011 Copyright (CC) SCS
Available online at www.shd.org.rs/JSCS/
704 ŠEATOVIĆ et al. 
to 40 °C (Table III). No loss of activity was detected after 15 min at 60 °C, but 
inactivation occurred when the incubation was continued for a longer period. A 
total loss of activity was observed after incubation at 80 °C. Heat-stability is a 
major feature of low-molecular-weight bacteriocins; however, some bacteriocins 
produced by Lactobacillus strains were inactivated by 10- to 15-min treatment at 
60–100 °C.25,26 
TABLE II. Antimicrobial activity of bacteriocin G2 detected after enzyme treatment, expres-
sed as residual bacteriocin activity 
Surfactant Residual bacteriocin activitya, % 
Catalase 100 
Proteinase K 40 
Pronase Е 100 
Chymotrypsin 100 
Trypsin 0 
Lysozyme 100 
Lipase 100 
α-Amylasе 100 
aThe percentage of the initial activity 
The activity of bacteriocin G2 was stable throughout the pH range 3–7 (Fig. 
1). Above pH 7, the activity decreased and was completely lost at pH 10. Bacte-
riocins differ greatly with respect to their sensitivity to pH. Many are conside-
rably more tolerant to acid than to alkaline pH values.27 As most bacteriocins and 
bacteriocin-like substances, bacteriocin G2 was also stable in acidic and neutral 
pH values, indicating that the substances are well adapted to the environment of 
the bacteria that produce them.28 
TABLE III. Antimicrobial activity of bacteriocin G2 detected after thermal treatment, expres-
sed as residual bacteriocin activity 
Treatment Residual bacteriocin activity, % 
40 °C, 15 min 100  
40 °C, 30 min 100  
40 °C, 60 min 100  
40 °C, 90 min 100  
60 °C, 15 min 100  
60 °C, 30 min 0 
60 °C, 60 min 0 
60 °C, 90 min 0 
80 °C, 15 min 0 
80 °C, 30 min 0 
80 °C, 60min 0 
80 °C, 90 min 0 
Autoclaving 121 °C, 15 min 0 
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To examine the hydrophobic nature of bacteriocin G2, the neutralized super-
natant was treated with surfactants at a final concentration of 1 % (w/v). The 
sensitivity to the surfactants is given in Table IV. Treatment with Tween 80 and 
urea resulted in increased antimicrobial activity. SDS and Triton X-100 had no 
effect on the bacteriocin activity. Many bacteriocins contain hydrophobic do-
mains and tend to form large aggregates. The large macromolecules can be dis-
aggregated by the use of surface-active compounds. Desegregation can result in a 
significant increase in bacteriocin activity.29 
Fig. 1 Effect of pH treatment on the 
activity of bacteriocin G2. 
TABLE IV. Effect of surfactants on bacteriocin G2 activity, expressed as residual bacteriocin 
activity 
Surfactant 
Residual bacteriocin activity, % 
Treated supernatant Surfactant control 
None (control) 100 – 
SDS 167 150 
Tween 80 133 0 
Triton X-100 117 108 
Urea 117 0 
Molecular mass determination 
Electrophoretic analysis of the concentrated supernatant of L. plantarum G2 
prepared using a sample buffer containing the reducing agent 2-mercaptoethanol 
showed a wide protein band occupying most of the gel. The gel slice overlaid 
with the indicator strain revealed a single clear inhibition band, corresponding to 
a molecular mass of 2.2 kDa. Similar molecular masses have been reported for a 
few other bacteriocins, including plantaricin A.9 A tendency of bacteriocins pro-
duced by other lactic acid bacteria to aggregate was reported, which might have 
contributed to the reason why the bacteriocins could not pass through a 5 kDa 
cut-off membrane.30,31 Bacteriocin G2 retained antimicrobial activity after treat-
ment with reducing agents indicating that it does not have intramolecular disul-
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phide bonds that are essential for its activity. Bacteriocin G2 resolved in non-re-
ducing tricine–SDS-PAGE, and subsequently overlaid with indicator strain showed 
a single clear band with the same molecular mass as found with the reducing gel. 
pI determination 
To determine the isoelelectric point of bacteriocin G2, isoelectric focusing 
was performed. A single clear inhibition band was detected on the part of the gel 
overlaid with the indicator strain, corresponding to a pI value of about 10. Bacte-
riocin G2 is a cationic protein, as are most bacteriocins.10 The high isoelectric 
point allows bacteriocins to interact at physiological pH with the anionic surface 
of bacterial membranes. 
CONCLUSIONS 
Based on the presented results, it may be concluded that the antimicrobial 
substance from the culture supernatant of L. plantarum G2 is a peptide with a 
diverse spectrum of antimicrobial activity. Stability in acidic and neutral pH 
range (up to pH 9), resistance to proteolytic cleavage but sensitivity to trypsin 
and heat stability at physiological temperatures allow bacteriocin G2 to be a 
competitive advantage of L. plantarum G2 probiotic preparations.  
И З В О Д  
ПАРЦИЈАЛНА КАРАКТЕРИЗАЦИЈА АНТИБАКТЕРИЈСКOГ ПЕПТИДА КОЈИ 
ПРОИЗВОДИ ПРОБИОТСКА БАКТЕРИЈА Lactobacillus plantarum G2 
СВЕТЛАНА Л. ШЕАТОВИЋ1, ЈЕЛЕНА С. ЈОВАНОВИЋ НОВАКОВИЋ1, ГОРДАНА Н. ЗАВИШИЋ1, 
ЖЕЉКА Ч. РАДУЛОВИЋ1, МАРИЈА Ђ. ГАВРОВИЋ–ЈАНКУЛОВИЋ2 и РАТКО М. ЈАНКОВ2 
1Galenika a.d., Batajni~ki drum bb, 11080 Zemun i 2Hemijski fakultet,Univeryitet u Beogradu, 
Studentski trg 12–16, 11000 Beograd 
Циљ овог истраживања је билa парцијална карактеризација антимикробног пептида из 
пробиотске бактерија Lactobacillus plantarum G2 изоловане из клиничког узорка здраве осо-бе. Антимикробно једињење из L. plantarum G2, означено као бактериоцин G2, добијено из супернатанта бактеријске културе, показало је широк спектар антимикробне активности, 
инхибирајићи раст свих испитиванх врста рода Lactobacillus, као и патогених бактерија Sta-
phylococcus aureus и Salmonella аbony. Бактериоцин G2 је осетљив на протеолитичко дејство трипсина и протеиназе K. Антимикробна активност је стабилна у опсегу 40–60 °C (15 мин), 
али се губи на температури од 80 °C. Установљено је да је бактериоцин стабилан на pH вред-
ностима између 2 и 9. Дејство Tween-а 80 и урее је довело до повећане инхибиторне актив-
ности. Према IEF, бактериоцин G2 је катјонски протеин, са pI вредношћу око 10, а моле-
куласка маса одређена на основу трицин–SDS-PAGE је 2,2 kDa. Пробиотски сој L plantarum 
G2 продукује антимикробно једињење протеинске структуре са карактеристикама бактерио-цина. Синтеза бактериоцина је једна од кључних особина пробиотских бактерија које имају 
клинички потенцијал као антиинфективни агенси, јер значајно повећава вероватноћу њихове 
in vivo ефикасности. 
(Примљено 5. јуна, ревидирано 15. октобра 2010) 
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